AKT1 and colorectal cancer: LC‒MS/MS was subsequently used to confirm that PRMT5 methylated AKT1 at R391.[27] Based on these findings, in our study, an antibody was also used to determine the methylarginine level of the AKT1‐R391K mutant in colorectal cancer cells when AKT was activated.